Clinical Trials
3 trialsNCT04763616 2026-04-27
ICING
Samsung Medical Center
Phase 2 Completed
NCT05804032 2026-02-18
Lenalidomide, Bortezomib and Dexamethasone Induction Therapy With Either Intravenous or Subcutaneous Isatuximab in Patients With Newly Diagnosed Multiple Myeloma
University of Heidelberg Medical Center
Phase 3 Completed
NCT04939844 2025-03-20
REST
Oslo University Hospital
Phase 2 Completed